A randomized trial of artemether-lumefantrine and dihydroartemisinin- piperaquine in the treatment of uncomplicated malaria among children in western Kenya

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Agarwal, Aarti ^a,c   McMorrow, Meredith ^c   Onyango, Peter ^b   Otieno, Kephas ^b   Odero, Christopher ^b   Williamson, John ^b   Kariuki, Simon ^b   Kachur, Stephen Patrick ^c   Slutsker, Laurence ^a   Desai, Meghna ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c U S PUBLIC HEALTH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; DIHYDROARTEMISININ PLUS PIPERAQUINE;

ARTICLE; AXILLA TEMPERATURE; CHILD; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG TREATMENT FAILURE; FEMALE; FEVER; FOLLOW UP; HUMAN; IN VIVO STUDY; INOCULATION; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PARASITE CLEARANCE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; REINFECTION; SCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; KENYA; MALARIA, FALCIPARUM; MALE; QUINOLINES; TREATMENT OUTCOME;

EID: 84880334173     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-254     Document Type: Article

References (29)

1. Spread of chloroquine resistance in Plasmodium falciparum. Payne D, Parasitol Today 1987 3 241 246 10.1016/0169-4758(87)90147-5 15462966 (Pubitemid 17142151)
2. Using evidence to change antimalarial drug policy in Kenya. Shretta R, Omumbo J, Rapuoda B, Snow RW, Trop Med Int Health 2000 5 755 764 10.1046/j.1365-3156.2000.00643.x 11123822 (Pubitemid 32001034)
3. Antimalarial drug resistance. White NJ, J Clin Invest 2004 113 1084 1092 15085184 (Pubitemid 38544090)
4. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
5. Combination therapy for malaria: the way forward? Nosten F, Brasseur P, Drugs 2002 62 1315 1329 10.2165/00003495-200262090-00003 12076181 (Pubitemid 34800094)
6. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ, JAMA 2007 297 2210 2219 10.1001/jama.297.20.2210 17519410
7. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW, Malar J 2007 6 72 10.1186/1475-2875-6-72 17535417 (Pubitemid 46919082)
8. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. Four Artemisinin-Based Combinations Study G, PLoS Med 2011 8 1001119 10.1371/journal.pmed.1001119 22087077
9. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Arinaitwe E, Sandison TG, Wanzira H, Kakuru A, Homsy J, Kalamya J, Kamya MR, Vora N, Greenhouse B, Rosenthal PJ, Tappero J, Dorsey G, Clin Infect Dis 2009 49 1629 1637 10.1086/647946 19877969
10. Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Menendez C, Nambozi M, Valea I, Nabasumba C, Sasi P, Bacchieri A, Corsi M, Ubben D, Talisuna A, D'Alessandro U, PLoS One 2009 4 7871 10.1371/journal.pone.0007871 19936217
11. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Yavo W, Faye B, Kuete T, Djohan V, Oga SA, Kassi RR, Diatta M, Ama MV, Tine R, Ndiaye JL, Evi JB, Same-Ekobo A, Faye O, Koné M, Malar J 2011 10 198 10.1186/1475-2875-10-198 21774826
12. Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. Nambozi M, Van Geertruyden JP, Hachizovu S, Chaponda M, Mukwamataba D, Mulenga M, Ubben D, D'Alessandro U, Malar J 2011 10 50 10.1186/1475-2875-10-50 21352609
13. Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies. Vestergaard LS, Ringwald P, Am J Trop Med Hyg 2007 77 153 159 18165488
14. WHO, Methods for surveillance of antimalarial drug efficacy Geneva: World Health Organization 2009
15. WHO, Recommended Genotyping Procedures (RGPs) to identify parasite populations version 1, edition Geneva: World Health Organization 2008
16. Division of Malaria Control [Ministry of Public Health and Sanitation] KNBoS, Macro aI, 2010 Kenya Malaria Indicator Survey Nairobi, Kenya: DOMC, KNBS and ICF Macro 2011
17. Evaluation of recurrent parasitemia after artemether-lumefantrine treatment for uncomplicated malaria in children in western Kenya. Woodring JV, Ogutu B, Schnabel D, Waitumbi JN, Olsen CH, Walsh DS, Heppner DG Jr, Polhemus ME, Am J Trop Med Hyg 2010 83 458 464 10.4269/ajtmh.2010.09-0403 20810804
18. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, Baidjoe AY, Manjurano A, Kavishe RA, Beshir KB, Yussuf RU, Omar SA, Hermsen CC, Okell L, Schallig HD, Sauerwein RW, Hallett RL, Bousema T, J Infect Dis 2013 207 1637 1645 10.1093/infdis/jit077 23468056
19. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Mens PF, Sawa P, van Amsterdam SM, Versteeg I, Omar SA, Schallig HD, Kager PA, Malar J 2008 7 237 10.1186/1475-2875-7-237 19017387
20. Artemisinin Resistance in Cambodia 1 Study C: Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
21. Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, Fruhauf H, Schaub B, Pfeil J, Peshu J, Hanpithakpong W, Rippert A, Juma E, Tsofa B, Mosobo M, Lowe B, Osier F, Fegan G, Lindegårdh N, Nzila A, Peshu N, Mackinnon M, Marsh K, PLoS One 2011 6 26005 10.1371/journal.pone.0026005 22102856
22. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya. Juma EA, Obonyo CO, Akhwale WS, Ogutu BR, Malar J 2008 7 262 10.1186/1475-2875-7-262 19102746
23. Update on artemisinin resistance 2012 April http://www.who.int/malaria/ publications/atoz/arupdate042012.pdf
24. Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. Beier JC, Perkins PV, Onyango FK, Gargan TP, Oster CN, Whitmire RE, Koech DK, Roberts CR, J Med Entomol 1990 27 570 577 2388233
25. Integrated malaria vector control with microbial larvicides and insecticide-treated nets in western Kenya: a controlled trial. Fillinger U, Ndenga B, Githeko A, Lindsay SW, Bull World Health Organ 2009 87 655 665 10.2471/BLT.08.055632 19784445
26. Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. Beier JC, Killeen GF, Githure JI, Am J Trop Med Hyg 1999 61 109 113 10432066 (Pubitemid 29344998)
27. Barriers to prompt and effective malaria treatment among the poorest population in Kenya. Chuma J, Okungu V, Molyneux C, Malar J 2010 9 144 10.1186/1475-2875-9-144 20507555
28. Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria. Creek D, Bigira V, Arinaitwe E, Wanzira H, Kakuru A, Tappero J, Kamya MR, Dorsey G, Sandison TG, Am J Trop Med Hyg 2010 83 873 875 10.4269/ajtmh.2010.10-0158 20889882
29. In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia. Hwang J, Alemayehu BH, Hoos D, Melaku Z, Tekleyohannes SG, Teshi T, Birhanu SG, Demeke L, Gobena K, Kassa M, Jima D, Reithinger R, Nettey H, Green M, Malone JL, Kachur SP, Filler S, Malar J 2011 10 209 10.1186/1475-2875-10-209 21798054